Length extensible implantable device and methods for making such devices

Abstract
A length extensible implantable device includes a porous member and a longitudinal constraining member. The longitudinal constraining member can constrain at least a portion, up to the entire length of, the porous member in the longitudinal direction. The length of the longitudinally constrained portion can be expanded by applying force to the porous member. The porous member may be a porous tubular member.
Description
TECHNICAL FIELD

This disclosure relates to length extensible implantable devices and methods for making such devices that may be used for providing a lumen for fluid flow in bodily cavities, organs, and vessels within a patient.


BACKGROUND

Medical devices are frequently used to treat the anatomy of patients. Such devices can be permanently or semi-permanently implanted in the anatomy to provide treatment to a patient. Frequently, these devices, including stents, grafts, stent-grafts, filters, valves, occluders, markers, mapping devices, therapeutic agent delivery devices, prostheses, pumps, bandages, and other endoluminal and implantable devices, are inserted into the body at an insertion point and delivered to a treatment site using a catheter.


Implantable devices such as grafts and stent-grafts are used in a variety of places in the human body to repair, support, and/or replace anatomical lumens, such as blood vessels, respiratory ducts, gastrointestinal ducts, and the like. Such devices can, for example, provide lumens for blood flow. In such configurations, flexible and durable devices are needed.


The selection of such implantable devices can pose potential issues. For example, the particularities of the anatomy of one patient may require a device having a different length than a device suitable for another patient. As a result, it may be difficult to determine the necessary size of a device, and, in many instances, the desired device size may be difficult to obtain.


As such, there is an ongoing need to provide devices, such as grafts and/or stent-grafts, which have adjustable length properties to provide a range of available lengths. Such devices may improve the ability of a treatment provider to properly size a device for the anatomy of a patient.


SUMMARY

In a first general aspect, a length extensible implantable device for supporting, repairing, and/or replacing a lumen in the body of a patient includes a porous tubular member capable of being extended to a desired length. The porous tubular member comprises a longitudinally compressed portion covered and maintained in the compressed configuration by a longitudinal constraining member. The longitudinal constraining member can comprise a film wrap or a perforated tube, among other structures.


In various implementations, a length extensible implantable device is formed by longitudinally compressing a porous tubular member, surrounding a portion of the tubular member with a longitudinal constraining member, and releasing the compressive force. In such implementations, the longitudinally constraining member constrains the portion of the tubular member in the longitudinally compressed configuration. The longitudinal constraining member can optionally be secured to the portion of the porous tubular member by, for example, an adhesive. More than one longitudinal constraining member can used. Further, more than one portion of the porous tubular member can be surrounded by one or more longitudinal constraining members.


The details of one or more embodiments are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and the drawings, and from the claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-1C are perspective views of various length extensible implantable devices in accordance with the present disclosure;



FIGS. 2A and 2B are schematic representations of a microstructure of ePTFE material of the prior art;



FIG. 3 is a perspective view of a length extensible implantable device in accordance with the present disclosure;



FIG. 4 is a perspective view of another length extensible implantable device in accordance with the present disclosure; and



FIGS. 5A-5D are perspective views of a length extensible implantable device in various stages.





Like reference symbols in the various drawings indicate like elements.


DETAILED DESCRIPTION OF THE DRAWINGS

This disclosure describes devices, systems, and methods that are useful, for example, for repairing, supporting, and/or replacing anatomical lumens. Several implantable medical devices are described herein, and in general any of the features described with respect to a particular device may also be used with any of the other devices described herein. In some examples, one or more features described with respect to a particular device may be added to or included with another device. Also, various combinations or sub-combinations of any of the features described herein may generally be used with any of the devices described herein.


In general, any of the implantable devices described herein can be delivered to, and deployed at, an in vivo deployment site within a body of a patient using variously minimally invasive surgical techniques. Likewise, these devices may also be surgically implanted via vascular surgical techniques.


Further, any of the implantable medical devices described herein can be delivered to, and deployed at, an in vivo deployment site within a body of a patient using various minimally invasive transcatheter deployment techniques. For example, any of the implantable medical devices described herein may be releasably attached to a delivery catheter, and the device and delivery catheter may be loaded into a delivery sheath. The delivery sheath may be introduced to the vasculature of the patient and advanced through the vasculature, until a distal end of the delivery sheath is located at or near the target in vivo deployment site. The implantable medical device may be deployed at the deployment site, for example, by retracting the delivery sheath and/or advancing the delivery catheter and the implantable medical device and detaching the implantable medical device from the delivery catheter. The delivery catheter and delivery sheath can then be withdrawn or retracted from the body of the patient.


Any of the implantable medical devices discussed herein can be used to repair, replace, and/or provide support to a body lumen. In various embodiments, implantable medical devices of the present disclosure can be used in a body lumen, including those within the circulatory and gastrointestinal systems.


As used herein, “implantable” means implanted in the body of a patient for more than 29 days.


As used herein, the term “constrain” means: (i) to limit extension, occurring either through self-expansion or assisted expansion, of the length of an implantable device; or (ii) to cover or surround, but not otherwise restrain, an implantable device such as for storage or biocompatibility reasons and/or to provide protection to the implantable device and/or the vasculature.



FIGS. 1A-1C describe perspective views of various example length extensible implantable devices 100 comprising a porous tubular member 102 and a longitudinal constraining member 104. Length extensible implantable device 100 can be implanted in the body of a patient either alone or in combination with one or more other components. For example, length extensible implantable device 100 can be combined with a suitable stent, forming a stent-graft. Further, length extensible implant 100 can be combined with other grafts and/or stent-grafts. In other embodiments, the length extensible graft 100 may be provided with a stent (or stent graft) on only one end or alternatively on more than one end or even each end of the length extensible graft 100. A stent graft is considered to be a stent provided with a graft covering all or a portion of the inner or outer surfaces of the stent or both the inner and outer surfaces of the stent. Devices with more than two ends are also contemplated, such as bifurcated devices. Any combination of length extensible implantable device 100 with any suitable medical device is within the scope of the present disclosure.


In various embodiments, porous tubular member 102 comprises a compressible, porous polymeric material, preferably an open celled material. For example, member 102 can comprise a porous expanded polymer, including expanded polytetrafluoroethylene (“ePTFE”), expanded modified PTFE (e.g. coated materials as described further below), expanded copolymers of PTFE, nylons, polycarbonates, polyethylenes, polypropylenes, polyurethanes and the like. These materials may also include materials having a porous fibrillated microstructure. It is also appreciated that these types of materials may be provided with coatings such as elastomeric coatings and coatings including therapeutic agents (e.g., heparin). Coatings may be provided as surface coatings or alternatively may partially or entirely impregnate the porous materials. Any suitable compressible porous polymer material is within the scope of the present disclosure.


Porous tubular member 102 can, for example, comprise an ePTFE construct. In various embodiments, porous tubular member 102 comprises a longitudinally extruded and longitudinally expanded ePTFE tube, such as the tubes described in U.S. Pat. Nos. 3,953,566 and 4,187,390. In other embodiments, polymeric tubular member 102 comprises a wrapped ePTFE film tube. For example, member 102 can comprises a tube made from an ePTFE film that has been cigarette wrapped on the surface of a mandrel or, alternatively, has been helically wrapped on the surface of a mandrel. Such ePTFE films of this type can be made generally as taught by U.S. Pat. Nos. 3,953,566 and 4,187,390. Likewise, conventional longitudinally extruded and expanded ePTFE tubes may be usefully reinforced with an external wrap of ePTFE film, typically, a helical wrap. However, any suitable porous ePTFE tubular member is within the scope of the present disclosure.


In various embodiments, porous tubular member 102 comprises an ePTFE tube having a multiplicity of fibrils which in turn can be connected to a multiplicity of nodes. The microstructure of porous tubular member 102 can comprise a multiplicity of fibrils having a mean fibril length. Mean fibril length can be determined, for example, by examining a photomicrograph of the surface of porous tubular member 102 and by taking the mean of ten measurements made in the predominant direction of the fibrils between nodes connected by fibrils. First, a photomicrograph is made of a representative region of the sample surface, of adequate magnification to show at least five sequential fibrils within the length of the photomicrograph. A series of five measurements are taken along a straight line drawn across the surface of the photomicrograph in the predominant direction of the fibrils followed by a second series of five measurements made along a second line drawn parallel to the first. A measurement constitutes the distance between adjacent nodes connected by at least one fibril. The ten measurements obtained by this method are meant to obtain the mean fibril length of the region.


For example, as illustrated in FIGS. 2A and 2B, porous tubular member 102 can comprise a microstructure of nodes 212, 222 interconnected by fibrils 214, 224.


In various embodiments, in the longitudinally uncompressed configuration, porous tubular member 102 can comprise a multiplicity of straight or unbent fibrils 214. Similarly, visual observation of a magnified longitudinal cross section of porous tubular member 102 indicates that a majority of the fibrils straight or unbent.


For example, after longitudinal compression, portion 110 of porous tubular member 102 comprises a multiplicity of bent fibrils 224. Similarly, visual observation of a magnified longitudinal cross section of portion 110 can indicate that a majority of the fibrils 224 connected to nodes 222 are relatively straight or unbent.


In various embodiments, at least a portion of porous tubular member 102 is held in a longitudinally compressed configuration by longitudinal constraining member 104. As illustrated in FIGS. 1A-1C, in such configurations, longitudinal constraining member 104 can surround a portion 110 of an abluminal surface of porous tubular member 102 and maintain portion 110 in the longitudinally compressed configuration. In various embodiments, portion 110 is the entire length of porous tubular member 102.


In various embodiments, portion 110 of porous tubular member 102, when compressed to the laterally compressed configuration, comprises a multiplicity of bent fibrils. In such embodiments, the mean fibril length in portion 110 is shorter than the mean fibril length of porous tubular member 102 in the initial, longitudinally uncompressed configuration. Further, visual observation of a magnified surface of portion 110 can indicate that a majority of the fibrils are relatively non-parallel and bent in relation to the longitudinal axis of the tubular member.


Longitudinal constraining member 104 can be capable of rupturing when force is applied in a particular direction. For example, in configurations in which a portion 110 of porous tubular member 102 is held in the longitudinal compressed configuration, applying tension to one or both ends of porous tubular member can cause longitudinal constraining member 104 to rupture. Rupture of longitudinal constraining member 104 can permit portion 110 to extend from the longitudinally compressed configuration to a less compressed configuration having fibrils that are less bent.


In other embodiments, longitudinal constraining member 104 can be ruptured by applying a radial force. For example, a balloon can be used to apply radial force to porous tubular member 102, rupturing longitudinal constraining member 104 and permitting extension of portion 110 to a lesser compressed configuration having fibrils that are less bent.


With reference to FIGS. 1A-1C, in various embodiments, longitudinal constraining member 104 can comprise a variety of different tubular forms. For example, longitudinal constraining member 104 can comprise an ePTFE film (e.g., a porous ePTFE film). In various embodiments, longitudinal constraining member 104 comprises an a ePTFE film having a multiplicity of nodes connected by fibrils, such as those taught by U.S. Pat. Nos. 3,953,566, 4,187,390, and 5,814,405. However, any film suitable of constraining portion 110 of porous tubular member 102 in a longitudinally compressed configuration is within the scope of the present disclosure.



FIG. 1A illustrates a film wrapped around the surface of porous tubular member 102 at a low angle in relation to a longitudinal axis of the porous tubular member. For example, the film can be wrapped between about 0° and 45° relative to the longitudinal axis of porous tubular member 102.


In various embodiments, as illustrated in FIG. 1B, longitudinal constraining member 104 can comprise a film wrapped around the surface of porous tubular member 102 at a higher angle in relation to the longitudinal axis of the porous tubular member. For example, the film can be wrapped between about 45° and 90° relative to the longitudinal axis of porous tubular member 102.


In yet other embodiments, longitudinal constraining member 104 can comprise a tubular member capable of rupturing upon the application of a sufficiently large force. Such a tubular member can comprise a tubular wall having a multiplicity of slits, holes, and/or perforations that facilitate rupturing. As illustrated in FIG. 1C, longitudinal constraining member 104 can comprise, for example, a perforated tube. Although described in relation to particular examples and embodiments, any tubular member capable of maintaining porous tubular member 102 in a longitudinally compressed configuration and rupturing upon application of sufficient force is within the scope of the present disclosure.


As illustrated in the perspective view of FIG. 3, implantable device 100 can comprise a first longitudinal constraining member 104 and a second longitudinal constraining member 334. For example, first longitudinal constraining member 104 can surround a first portion 110 of porous tubular member 102, and second longitudinal constraining member 334 can surround a second portion 330 of porous tubular member 102.


In various embodiments, first portion 110 and second portion 330 can comprise at least a part of the same portion, such that second longitudinal constraining member 334 surrounds first longitudinal constraining member 104. For example, the perspective view of FIG. 4 illustrates second longitudinal constraining member 334 surrounding second portion 330 and a part of first portion 110. Any configuration of first and second longitudinal constraining members, including partial or complete overlap of the two constraining members, is within the scope of the present disclosure. Further, the use of any number of longitudinal constraining members is within the scope of the present disclosure.


First longitudinal constraining member 104 and/or second longitudinal constraining member 334 can optionally be secured to porous tubular member 102, for example, to maintain the longitudinal constraining members in a desired orientation and position relative to porous tubular member 102. For example, first longitudinal constraining member 104 and/or second longitudinal constraining member 334 can be secured to porous tubular member 102 by applying an adhesive to a segment of an abluminal surface of porous tubular member 102 and/or the inner surface of the longitudinal constraining members. In various embodiments, a thermoplastic polymer adhesive, including a tetrafluoroethylene and perfluoromethyl vinyl ether copolymer, such as those described in U.S. Pat. No. 7,462,675, can be used. In other embodiments, a fluoroelastomer adhesive, such as a FEP, can be used. Any means capable of securing first longitudinal constraining member 104 and/or second longitudinal constraining member 334 to first porous tubular member 102 is within the scope of the present disclosure.


A method for making a length extensible implantable device of the present disclosure is described as follows. A porous tubular member in a longitudinally uncompressed configuration is obtained and fitted coaxially over a mandrel having an outside diameter the same as or slightly larger than the inside diameter of the porous tubular member. The tubular member is longitudinally compressed by a compressive force so that the length of the tube is reduced to a desired length. A longitudinal constraining member is placed over at least a portion of the porous tubular member to maintain the portion of the member in the longitudinally compressed configuration. The longitudinal constraining member can optionally be secured to the porous tubular member. The compressive force on the porous tubular member is released, and the longitudinally compressed porous tubular member is removed from the mandrel.



FIGS. 5A-5D illustrate a porous tubular member in various stages of a method for forming the porous tubular member into a length extensible implantable device. For example, FIG. 5A illustrates porous tubular member 102 in an initial, longitudinally uncompressed configuration. In the longitudinally uncompressed configuration, porous tubular member 102 can comprise a length custom character1.



FIG. 5B illustrates porous tubular member 102 after a compressive force is applied. As the compressive force is applied, porous tubular member 102 is compressed from the initial, longitudinally uncompressed configuration to the longitudinally compressed configuration. In the longitudinally compressed configuration, porous tubular member 102 has a length custom character2, which is shorter than custom character1. In various embodiments, porous tubular member 102 is biased such that, upon release of the compressive force, it will at extend from custom character2 at least partially back to custom character1.


In various embodiments, custom character2 can comprise a length that is between about 50% and 75% of custom character1, such that compression from custom character1 to custom character2 reduces the length of porous tubular member 102 to between 50% and 75% of its uncompressed length. In other embodiments, custom character2 can comprise a length that is between about 25% and 50% of custom character1. In yet other embodiments, custom character2 can comprise a length that is between about 5% and 25% of custom character1. Any relationship between custom character2 and custom character1 is within the scope of the present disclosure.


After porous tubular member 102 is compressed to a desired length custom character2, at least one longitudinal constraining member 104 is applied around the abluminal surface of porous tubular member 102 to maintain at least a portion 110 of porous tubular member 102 in the longitudinally compressed configuration. For example, FIG. 5C illustrates porous tubular member 102 covered by longitudinal constraining member 104. In various embodiments, and as illustrated in FIG. 5C, portion 110 covered by longitudinal constraining member 104 can comprise the entire length (custom character2) of porous tubular member 102. In other embodiments, portion 110 is less than the entire length of porous tubular members.


In various embodiments, longitudinal constraining member 104 comprises a film. In such embodiments, the film is wrapped around portion 110 of porous tubular member 102 in the longitudinally compressed configuration. As previously discussed, the film can be wrapped at a relatively low (about 0° to 45°) or a relatively high (about 45° to 90°) wrap angle relative to a longitudinal axis of porous tubular member 102. The film can also be wrapped at multiple angles, such as embodiments in which multiple layers of film are wrapped in multiple directions along the abluminal surface of porous tubular member 102.


In other embodiments, longitudinal constraining member 104 comprises a tubular element, such as a perforated tube. In such configurations, the tubular element is fitted along the surface of portion 110 of porous tubular member 102 in the longitudinally compressed configuration.


Longitudinal constraining member 104 can optionally be secured to porous tubular member 102. For example, an adhesive can be applied to the abluminal surface of porous tubular member 102. In other examples, an adhesive can be applied to the inner surface of longitudinal constraining member 104. However, as mentioned above, any manner of securing a longitudinal constraining member to a porous tubular member is within the scope of the present disclosure.


After portion 110 of porous tubular member 102 has been secured in the longitudinally compressed configuration by at least one longitudinal constraining member 104, the compressive force used to shorten porous tubular member 102 from custom character1 to custom character2 can be relieved while longitudinal constraining member 104 maintains portion 110 in a compressed configuration, forming length extensible implantable device 100. If portion 110 comprises less than the entire length of porous tubular member 102, upon release of the compressive force, the segment of porous tubular member 102 not constrained can expand to its original length, leaving only portion 110 in the longitudinally compressed configuration. In embodiments in which the entirety length of porous tubular member 102 is covered by longitudinal constraining member 104 (in other words, where portion 110 is equal to custom character2), all of porous tubular member 102 remains in the longitudinally compressed configuration.


In various embodiments, a second porous tubular member can be positioned around portion 110, portion 330, and or all of porous tubular member 102. In such configurations, longitudinal constraining members 104 and/or 334 are sandwiched between porous tubular member 102 and a second porous tubular member, such that longitudinal constraining members 110 and/or 330 cannot be seen when visually examining the outer surface of length extensible implantable device 100.


After length extensible implantable device 100 is formed, it can be adjusted and configured for use within the body of a patient. In various embodiments, as illustrated in FIG. 5D, the length of length extensible implantable device 100 can be expanded to a length custom character3, which is greater than custom character2 and less than or equal to the length of porous tubular member 102 in the initial, laterally uncompressed configuration (having a length of custom character1). In various embodiments, as force is applied to porous tubular member 102, longitudinal constraining member 104 can rupture or tear, forming one or more ruptures 540. Once sufficient force is applied, porous tubular member 102 can continue expanding until it has expanded back to custom character1.


In various embodiments, portion 110 of porous tubular member 102 can be extended from the longitudinally compressed configuration to a longer length (such as custom character3) by applying a force parallel to the longitudinal axis of porous tubular member 102. In other embodiments, portion 110 of porous tubular member 102 can be extended from the longitudinally compressed configuration to custom character3 by applying a radial force to portion 110.


For example, a treatment provider can determine a desired length of length extensible implantable device 100 before implanting the device into the vasculature of a patient. In other cases, the treatment provider can determine the desired length of length extensible implantable device 100 during the course of implanting the device into the vasculature and delivering the device to a treatment area of the patient.


Several characteristics and advantages have been set forth in the preceding description, including various alternatives together with details of the structure and function of the devices and methods. The disclosure is intended as illustrative only and as such is not intended to be exhaustive or limiting. It will be evident to those skilled in the art that various modifications may be made, especially in matters of structure, materials, elements, components, shapes, sizes, and arrangements of parts including combinations within the principles described herein, to the full extent indicated by the broad, general meaning of the terms in which the appended claims are expressed. To the extent that these various modifications depart from the spirit and scope of the appended claims, they are intended to be encompassed therein.

Claims
  • 1. An implantable device configured to be implanted in a body of a patient, the implantable device comprising: a porous member comprising a microstructure including a multiplicity of fibrils, wherein the porous member comprises a longitudinally uncompressed configuration and a longitudinally compressed configuration, wherein a mean fibril length in the longitudinally uncompressed configuration is greater than a mean fibril length in the longitudinally compressed configuration; anda first longitudinal constraining member covering a first portion of an abluminal surface of the porous member and configured to maintain the first portion of the abluminal surface of the porous member in the longitudinally compressed configuration for implantation in the body of the patient to repair, support, and/or replace at least a portion of a body lumen, the first longitudinal constraining member comprising a porous film.
  • 2. The implantable device of claim 1, further comprising at least a second longitudinal constraining member.
  • 3. The implantable device of claim 2, wherein the first and second longitudinal constraining members cover different portions of the abluminal surface of the porous member.
  • 4. The implantable device of claim 1, wherein the first constraining member is a cylindrical perforated sleeve of porous film.
  • 5. The implantable device of claim 4, wherein perforations of the first constraining member are configured to facilitate rupturing of the first longitudinal constraining member.
  • 6. The implantable device of claim 4, wherein the porous film is a cylindrical perforated sleeve of porous film including at least one of slits, holes, and perforations.
  • 7. The implantable device of claim 1, wherein the first longitudinal constraining member is configured to rupture upon application of at least one of a radial force and a longitudinal force to the implantable device.
  • 8. The implantable device of claim 7, wherein the rupture of the first longitudinal member can permit the first portion of the abluminal surface to extend from the longitudinally compressed configuration to a less compressed configuration.
  • 9. The implantable device of claim 8, wherein a mean fibril length in the less compressed configuration is greater than the mean fibril length in the longitudinally compressed configuration and less than the mean fibril length in the longitudinally uncompressed configuration.
  • 10. The implantable device of claim 7, wherein the porous member has a first length in the longitudinally compressed configuration and upon application of the radial force, the porous member can be extended from the first length to a second length where the second length is longer than the first length.
  • 11. The implantable device of claim 1, wherein the porous film is a cylindrical member.
  • 12. The implantable device of claim 11, wherein the porous member comprises an ePTFE film.
  • 13. The implantable device of claim 12, wherein the ePTFE film is helically wrapped.
  • 14. An implantable device configured to be implanted in a body of a patient, the implantable device comprising: a porous member comprising a microstructure including a multiplicity of fibrils, wherein the porous member comprises a longitudinally uncompressed configuration and a longitudinally compressed configuration, wherein a mean fibril length in the longitudinally uncompressed configuration is greater than a mean fibril length in the longitudinally compressed configuration;a first longitudinal constraining member covering a first portion of the abluminal surface of the porous member and secured to the first portion of the abluminal surface via an adhesive, the first longitudinal constraining member configured to maintain the first portion of the abluminal surface of the porous member in the longitudinally compressed configuration at least until implantation in the body of the patient to repair, support, and/or replace at least a portion of a body lumen, the first longitudinal constraining member comprising a porous film; anda second longitudinal constraining member covering a second portion of the abluminal surface of the porous member and secured to the second portion of the abluminal surface via an adhesive, the second longitudinal constraining member configured to maintain the second portion of the abluminal surface of the porous member in the longitudinally compressed configuration for implantation in the body of the patient,wherein application of a longitudinal force onto the first longitudinal constraining member causes release of the first longitudinal constraining member from the first portion such that the first portion extends to the longitudinally uncompressed configuration.
  • 15. The implantable device of claim 14, wherein application of the longitudinal force onto the second longitudinal constraining member causes release of the second longitudinal constraining member from the second portion.
  • 16. The implantable device of claim 14, wherein the first longitudinal member is a porous film member including at least one of slits, holes, and perforations.
  • 17. The implantable device of claim 16, wherein the first longitudinal constraining member is configured to rupture along the at least one of slits, holes, and perforations.
  • 18. The implantable device of claim 14, wherein the second longitudinal member is a porous film member including at least one of slits, holes, and perforations.
  • 19. An implantable device configured to be implanted in a body of a patient, the implantable device comprising: a porous member including a microstructure including a multiplicity of fibrils, wherein the porous member comprises a longitudinally uncompressed configuration and a longitudinally compressed configuration, wherein a mean fibril length in the longitudinally uncompressed configuration is greater than a mean fibril length in the longitudinally compressed configuration; anda first longitudinal constraining member including a cylindrical perforated sleeve, the first longitudinal constraining member covering a first portion of an abluminal surface of the porous member and configured to maintain the first portion of the abluminal surface of the porous member in the longitudinally compressed configuration for implantation in the body of the patient to repair, support, and/or replace at least a portion of a body lumen.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. patent application Ser. No. 14/558,296, filed Dec. 2, 2014, now U.S. Pat. No. 10,842,918, issued Nov. 24, 2020, which claims the benefit of U.S. Provisional Application 61/912,414, filed Dec. 5, 2013, both of which are incorporated herein by reference in their entireties for all purposes.

US Referenced Citations (203)
Number Name Date Kind
3953566 Gore Apr 1976 A
4187390 Gore Feb 1980 A
4332035 Mano Jun 1982 A
4877661 House et al. Oct 1989 A
4955899 Della et al. Sep 1990 A
5026513 House et al. Jun 1991 A
5064435 Porter Nov 1991 A
5071609 Tu et al. Dec 1991 A
5476589 Bacino Dec 1995 A
5534007 St et al. Jul 1996 A
5549663 Cottone, Jr. Aug 1996 A
5673102 Suzuki et al. Sep 1997 A
5708044 Branca Jan 1998 A
5718973 Lewis et al. Feb 1998 A
5749852 Schwab et al. May 1998 A
5752934 Campbell et al. May 1998 A
5759192 Saunders Jun 1998 A
5769884 Solovay Jun 1998 A
5772884 Tanaka et al. Jun 1998 A
5788626 Thompson Aug 1998 A
5814405 Branca et al. Sep 1998 A
5824043 Cottone, Jr. Oct 1998 A
5843158 Lenker et al. Dec 1998 A
5843161 Solovay Dec 1998 A
5843171 Campbell Dec 1998 A
5853419 Imran Dec 1998 A
5925061 Ogi et al. Jul 1999 A
5935162 Dang Aug 1999 A
5957974 Thompson et al. Sep 1999 A
6010529 Herweck et al. Jan 2000 A
6013854 Moriuchi Jan 2000 A
6042588 Munsinger et al. Mar 2000 A
6042605 Martin et al. Mar 2000 A
6042606 Frantzen Mar 2000 A
6110198 Fogarty et al. Aug 2000 A
6156064 Chouinard Dec 2000 A
6161399 Jayaraman Dec 2000 A
6165211 Thompson Dec 2000 A
6174329 Callol et al. Jan 2001 B1
6190406 Duerig et al. Feb 2001 B1
6217609 Haverkost Apr 2001 B1
6245012 Kleshinski Jun 2001 B1
6261320 Tam et al. Jul 2001 B1
6261620 Leadbeater Jul 2001 B1
6315791 Gingras et al. Nov 2001 B1
6336937 Vonesh et al. Jan 2002 B1
6352552 Levinson et al. Mar 2002 B1
6379382 Yang Apr 2002 B1
6436132 Patel et al. Aug 2002 B1
6461665 Scholander Oct 2002 B1
6488701 Nolting et al. Dec 2002 B1
6541589 Baillie Apr 2003 B1
6620190 Colone Sep 2003 B1
6626939 Burnside et al. Sep 2003 B1
6673102 Vonesh et al. Jan 2004 B1
6673107 Brandt et al. Jan 2004 B1
6730120 Berg et al. May 2004 B2
6755856 Fierens et al. Jun 2004 B2
6758858 McCrea et al. Jul 2004 B2
6890350 Walak May 2005 B1
7022132 Kocur Apr 2006 B2
7049380 Chang et al. May 2006 B1
7083642 Sirhan et al. Aug 2006 B2
7105018 Yip et al. Sep 2006 B1
7306729 Bacino et al. Dec 2007 B2
7419678 Falotico Sep 2008 B2
7462675 Chang et al. Dec 2008 B2
7531611 Sabol et al. May 2009 B2
7704274 Boyle et al. Apr 2010 B2
7789908 Sowinski et al. Sep 2010 B2
7811314 Fierens et al. Oct 2010 B2
7815763 Fierens et al. Oct 2010 B2
7887562 Young et al. Feb 2011 B2
7927364 Fierens et al. Apr 2011 B2
7927365 Fierens et al. Apr 2011 B2
7935141 Randall et al. May 2011 B2
7967829 Gunderson et al. Jun 2011 B2
8048440 Chang et al. Nov 2011 B2
8545525 Surti et al. Oct 2013 B2
8585753 Scanlon et al. Nov 2013 B2
8728103 Surti et al. May 2014 B2
8801774 Silverman Aug 2014 B2
8936634 Irwin et al. Jan 2015 B2
9241695 Peavey et al. Jan 2016 B2
9345601 Jantzen et al. May 2016 B2
9399085 Cleek et al. Jul 2016 B2
9554786 Carley et al. Jan 2017 B2
9681948 Levi et al. Jun 2017 B2
9737422 Armstrong et al. Aug 2017 B2
9795496 Armstrong et al. Oct 2017 B2
9833343 Burnside et al. Dec 2017 B2
9839540 Armstrong et al. Dec 2017 B2
9931193 Cully et al. Apr 2018 B2
10166128 Armstrong et al. Jan 2019 B2
10279084 Goepfrich et al. May 2019 B2
10335298 Armstrong et al. Jul 2019 B2
10507124 Armstrong et al. Dec 2019 B2
11116621 Cully et al. Sep 2021 B2
11357611 Cully et al. Jun 2022 B2
20010053929 Vonesh et al. Dec 2001 A1
20020038140 Yang et al. Mar 2002 A1
20020076542 Kramer et al. Jun 2002 A1
20020161388 Samuels et al. Oct 2002 A1
20020198588 Armstrong et al. Dec 2002 A1
20030055494 Bezuidenhout et al. Mar 2003 A1
20030060871 Hill et al. Mar 2003 A1
20030180488 Lim et al. Sep 2003 A1
20040024442 Sowinski et al. Feb 2004 A1
20040024448 Chang et al. Feb 2004 A1
20040044400 Cheng et al. Mar 2004 A1
20040044401 Bales et al. Mar 2004 A1
20040093065 Yachia et al. May 2004 A1
20040133266 Clerc et al. Jul 2004 A1
20040162606 Thompson Aug 2004 A1
20040170782 Wang et al. Sep 2004 A1
20040224442 Grigg Nov 2004 A1
20040260277 Maguire Dec 2004 A1
20050080476 Gunderson et al. Apr 2005 A1
20050137680 Ortiz et al. Jun 2005 A1
20050273149 Tran et al. Dec 2005 A1
20050283224 King Dec 2005 A1
20060009835 Osborne et al. Jan 2006 A1
20060015171 Armstrong Jan 2006 A1
20060036311 Nakayama et al. Feb 2006 A1
20060106337 Blankenship May 2006 A1
20060118236 House et al. Jun 2006 A1
20060135985 Cox et al. Jun 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060190070 Dieck et al. Aug 2006 A1
20060259133 Sowinski et al. Nov 2006 A1
20060271091 Campbell et al. Nov 2006 A1
20060276883 Greenberg et al. Dec 2006 A1
20070012624 Bacino et al. Jan 2007 A1
20070060999 Randall et al. Mar 2007 A1
20070088421 Loewen Apr 2007 A1
20070129786 Beach et al. Jun 2007 A1
20070207186 Scanlon et al. Sep 2007 A1
20070207816 Spain Sep 2007 A1
20070208421 Quigley Sep 2007 A1
20070213800 Fierens et al. Sep 2007 A1
20070250146 Cully et al. Oct 2007 A1
20070250153 Cully et al. Oct 2007 A1
20070254012 Ludwig et al. Nov 2007 A1
20080051876 Ta et al. Feb 2008 A1
20080097301 Alpini et al. Apr 2008 A1
20080097401 Trapp et al. Apr 2008 A1
20080097579 Shanley et al. Apr 2008 A1
20080097582 Shanley et al. Apr 2008 A1
20080119943 Armstrong et al. May 2008 A1
20080319531 Doran et al. Dec 2008 A1
20090005854 Huang et al. Jan 2009 A1
20090030499 Bebb et al. Jan 2009 A1
20090036976 Beach et al. Feb 2009 A1
20090043373 Arnault et al. Feb 2009 A1
20090104247 Pacetti Apr 2009 A1
20090182413 Burkart et al. Jul 2009 A1
20090264989 Bonhoeffer et al. Oct 2009 A1
20090306762 McCullagh et al. Dec 2009 A1
20090306766 McDermott et al. Dec 2009 A1
20100016940 Shokoohi et al. Jan 2010 A1
20100094394 Beach et al. Apr 2010 A1
20100094405 Cottone Apr 2010 A1
20100106240 Duggal et al. Apr 2010 A1
20100159171 Clough Jun 2010 A1
20100211166 Miller Aug 2010 A1
20100256738 Berglund Oct 2010 A1
20100286760 Beach et al. Nov 2010 A1
20100305682 Furst Dec 2010 A1
20110009953 Luk et al. Jan 2011 A1
20110087318 Daugherty et al. Apr 2011 A1
20120323211 Ogle et al. Dec 2012 A1
20130131780 Armstrong et al. May 2013 A1
20130183515 White Jul 2013 A1
20130184807 Kovach et al. Jul 2013 A1
20130197624 Armstrong et al. Aug 2013 A1
20130204347 Armstrong et al. Aug 2013 A1
20130245745 Vong et al. Sep 2013 A1
20130253466 Campbell et al. Sep 2013 A1
20130297003 Pinchuk Nov 2013 A1
20140121746 Kusleika May 2014 A1
20140135897 Cully et al. May 2014 A1
20140172066 Goepfrich et al. Jun 2014 A1
20140180402 Bruchman et al. Jun 2014 A1
20150005870 Kovach et al. Jan 2015 A1
20150157770 Cully et al. Jun 2015 A1
20150313871 Li et al. Nov 2015 A1
20160015422 De et al. Jan 2016 A1
20160184079 Scutti et al. Jun 2016 A1
20170065400 Armstrong et al. Mar 2017 A1
20170105854 Treacy et al. Apr 2017 A1
20170106176 Taft et al. Apr 2017 A1
20170216062 Armstrong et al. Aug 2017 A1
20180177583 Cully et al. Jun 2018 A1
20190125517 Cully et al. May 2019 A1
20190209739 Goepfrich et al. Jul 2019 A1
20190216592 Cully et al. Jul 2019 A1
20200022828 Armstrong et al. Jan 2020 A1
20200179663 McDaniel et al. Jun 2020 A1
20200237497 Silverman et al. Jul 2020 A1
20210038413 Cully et al. Feb 2021 A1
20210068996 Armstrong et al. Mar 2021 A1
20210077246 Cully et al. Mar 2021 A1
20210236139 Connor Aug 2021 A1
Foreign Referenced Citations (80)
Number Date Country
2462509 Apr 2003 CA
101420913 Apr 2009 CN
101926699 Dec 2010 CN
201744060 Feb 2011 CN
102015009 Apr 2011 CN
103945796 Jul 2014 CN
105025848 Nov 2015 CN
0293090 Nov 1988 EP
0313263 Apr 1989 EP
0582870 Feb 1994 EP
0775472 May 1997 EP
0815806 Jan 1998 EP
0893108 Jan 1999 EP
1666003 Jun 2006 EP
1946721 Jul 2008 EP
2255750 Dec 2010 EP
02-000645 Jan 1990 JP
09-241412 Sep 1997 JP
11-197252 Jul 1999 JP
11-290448 Oct 1999 JP
11-512635 Nov 1999 JP
2001-509702 Jul 2001 JP
2002-531219 Sep 2002 JP
2007-526098 Sep 2007 JP
2008-506459 Mar 2008 JP
2008-173461 Jul 2008 JP
2010-500107 Jan 2010 JP
2010-504174 Feb 2010 JP
2010-535075 Nov 2010 JP
2015-502205 Jan 2015 JP
2015-513931 May 2015 JP
2018-134425 Aug 2018 JP
2019-048083 Mar 2019 JP
2019-514493 Jun 2019 JP
2021-122433 Aug 2021 JP
2021-168971 Oct 2021 JP
9416802 Aug 1994 NO
2124986 Jan 1999 RU
9413224 Jun 1994 WO
9505555 Feb 1995 WO
9509586 Apr 1995 WO
9607370 Mar 1996 WO
9640348 Dec 1996 WO
9710871 Mar 1997 WO
9926558 Jun 1999 WO
0041649 Jul 2000 WO
0047271 Aug 2000 WO
0164278 Sep 2001 WO
0174272 Oct 2001 WO
0260506 Aug 2002 WO
0303946 Jan 2003 WO
0320175 Mar 2003 WO
2004000375 Dec 2003 WO
2006019626 Feb 2006 WO
2006058322 Jun 2006 WO
2008021002 Feb 2008 WO
2008028964 Mar 2008 WO
2008036870 Mar 2008 WO
2008049045 Apr 2008 WO
2008021006 Aug 2008 WO
2008097589 Aug 2008 WO
2009017827 Feb 2009 WO
2009100210 Aug 2009 WO
2009108355 Sep 2009 WO
2010006783 Jan 2010 WO
2010008570 Jan 2010 WO
2010030766 Mar 2010 WO
2010132707 Nov 2010 WO
2010150208 Dec 2010 WO
2011098565 Aug 2011 WO
2012011261 Jan 2012 WO
2012099979 Jul 2012 WO
2012158944 Nov 2012 WO
2013074663 May 2013 WO
2013074990 May 2013 WO
2013109337 Jul 2013 WO
2013138789 Sep 2013 WO
2017038145 Mar 2017 WO
2017184153 Oct 2017 WO
2019074869 Apr 2019 WO
Non-Patent Literature Citations (28)
Entry
European Search Report and Search Opinion Received for EP Application No. 16899644.5, dated Oct. 30, 2019, 8 pages.
European Search Report and Search Opinion Received for EP Application No. 18167101, dated Jul. 25, 2018, 9 pages.
European Search Report from EP16196687.4, dated Nov. 21, 2017, 5 pages.
Extended European Search Report issued in EP Application No. 17186750.0, dated Oct. 24, 2017, 7 pages.
International Preliminary Report on Patentability issued in PCT/US2016/028671, dated Nov. 1, 2018, 12 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US11/61165, dated Jul. 25, 2013, 14 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US12/65066, dated May 30, 2014, 14 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US14/68430, dated Jun. 16, 2016, 8 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2013/076405, dated Jul. 2, 2015, 10 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2014/013496, dated Aug. 11, 2016, 7 pages.
International Search Report and Written Opinion for Application No. PCT/US2016/028671 dated Jul. 28, 2016.
International Search Report and Written Opinion for Application No. PCT/US2016/028671, dated Jul. 28, 2016, 19 pages.
International Search Report and Written Opinion for PCT/US2012/064908 dated Feb. 4, 2013, corresponding to U.S. Appl. No. 13/675,730, 11 pages.
International Search Report and Written Opinion for PCT/US2012/066518, dated Feb. 4, 2013, corresponding to U.S. Appl. No. 13/351,052, 12 pages.
International Search Report and Written Opinion for PCT/US2014/068430 dated Feb. 20, 2015, corresponding to U.S. Appl. No. 14/558,296, 9 pages.
International Search Report and Written Opinion issued in PCT/US2011/061165, dated Oct. 1, 2012, 20 pages.
International Search Report and Written Opinion issued in PCT/US2012/066518, dated Feb. 4, 2013, 10 pages.
International Search Report and Written Opinion issued in PCT/U.S. Pat. No. 2012065066, dated Nov. 11, 2013, 9 pages.
International Search Report for PCT/US2013/076405 dated May 6, 2014, corresponding to U.S. Appl. No. 14/132,767, 8 pages.
International Search Report for PCT/US2014/013496 dated Dec. 2, 2014, corresponding to U.S. Appl. No. 13/755,481, 4 pages.
International Search Report issued in PCT/US2013/076405, dated May 6, 2014, 7 pages.
International Search Report issued in PCT/US2014/013496, dated Dec. 2, 2014, 3 pages.
International Written Opinion received for PCT Patent Application No. PCT/US2014/013496, dated Dec. 2, 2014, 5 pages.
Nakayama, Yasuhide. Microporous Stent Achieves Brain Aneurysm Occlusion Without Disturbing Branching Flow. NeuroNews Nov. 2012; 8:1-2.
Nishi S, Nakayama Y, Ishibashi-Ueda FI, Okamoto Y, Yoshida M. Development of microporous self-expanding stent grafts for treating cerebral aneurysms: designing micropores to control intimal hyperplasia. J Artif Organs 2011; 14:348-356.
Nishi S, Nakayama Y, Ishibashi-Ueda H, Okamoto Y, Yoshida M. Development of microporous self-expanding stent grafts for treating cerebral aneurysms: designing micropores to control intimal hyperplasia. J Artif Organs 2011; 14:348-356.
Partial International Search Report for PCT/US2012/065066, dated Jul. 1, 2013, corresponding to U.S. Appl. No. 13/675,959, 3 pages.
Bent definition and meaning, Collins English Dictionary,https://www.collinsdictionary.com/us/dictionary/english/bent, accessed May 27, 2022 (Year: 2022).
Related Publications (1)
Number Date Country
20210138121 A1 May 2021 US
Provisional Applications (1)
Number Date Country
61912414 Dec 2013 US
Divisions (1)
Number Date Country
Parent 14558296 Dec 2014 US
Child 16953662 US